Related Experiment Video
Updated: Jul 26, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Targeted Therapy and Personalized Medicine
Rida Fatima Saeed1, Uzma Azeem Awan2, Sidra Saeed3
1Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan. rida.saeed@numspak.edu.pk.
Personalized medicine and targeted therapies revolutionize cancer care by focusing on molecular analysis for individualized treatment. This approach enhances early diagnosis, optimal drug selection, and predictable patient outcomes.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- The paradigm in cancer research is shifting from organ-centric to personalized strategies.
- Deep molecular analysis of tumors guides individualized treatment selection.
- Targeted therapies leverage molecular characterization for optimal cancer care.
Purpose of the Study:
- To review advancements in targeted therapies and personalized medicine for various cancers.
- To discuss the role of molecular profiling in treatment and prognosis.
- To highlight recent FDA-approved targeted therapies and address drug resistance.
Main Methods:
- Review of current literature on targeted therapies and personalized medicine.
- Analysis of molecular profiling techniques (genetic, immunological, proteomic).
- Examination of FDA-approved targeted therapies and anti-cancer regimens.
Main Results:
- Personalized medicine enables tailored therapeutic alternatives and prognostic information.
- Advancements in diagnostic tools and clinical trials for molecular targets are noted.
- Understanding drug resistance is crucial for effective anti-cancer regimens.
Conclusions:
- Personalized medicine and targeted therapies are transforming cancer treatment and prevention.
- Further research is needed to address limitations and optimize individualized health planning.
- Emphasis on target therapies in diagnostics and therapeutics is key for future cancer care.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...